Abstract
BackgroundConducting Controlled Human Malaria Infection (CHMI) studies in sub-Saharan Africa presents unique challenges yet it provides enormous opportunities for fast-tracking malaria vaccine and drug development. Sanaria Inc. USA, has devised...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have